Hydrochloric Acid → HCID 178422578, compound
Reaction equation
[CH3:1][C:2]1[CH:3]=[C:4]([C:15]2[CH:16]=[C:17]3[C:22](=[CH:23][C:24]=2[C:25]([F:28])([F:27])[F:26])[NH:21][C:20](=[O:29])[N:19]([NH:30][S:31]([CH3:34])(=[O:33])=[O:32])[C:18]3=[O:35])[N:5](CCOC[Si](C)(C)C)[N:6]=1.Cl.CCO>O1CCOCC1>[CH3:1][C:2]1[CH:3]=[C:4]([C:15]2[CH:16]=[C:17]3[C:22](=[CH:23][C:24]=2[C:25]([F:27])([F:28])[F:26])[NH:21][C:20](=[O:29])[N:19]([NH:30][S:31]([CH3:34])(=[O:33])=[O:32])[C:18]3=[O:35])[NH:5][N:6]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 60 °C
Procedure
To a solution of N-{6-[5-methyl-2-(2-trimethylsilanylmethoxy-ethyl)-2H-pyrazol-3-yl]-2,4-dioxo-7-trifluoromethyl-1,4-dihydro-2H-quinazolin-3-yl}-methanesulfonamide (140 mg, 0.26 mmol) in dioxane (5 mL) was added a solution of HCl in EtOH (1N, 0.6 mL, 2 equiv). The solution was stirred at 60° C. for 4 h. The solvent was removed in vacuo and the resulting paste was sonicated in 5 mL of DCM. The solid was filtered off, washed with DCM and dried in vacuo to afford N-[6-(5-methyl-2H-pyrazol-3-yl)-2,4-dioxo-7-trifluoromethyl-1,4-dihydro-2H-quinazolin-3-yl]-methanesulfonamide (59 mg, 56%) as a white solid. (ESI-MS: m/z 445.4 [M+CH3CN+H]+, rt 4.16 min)). 1H-NMR (DMSO-d6, 400 MHz) 12.0 (s, 1H), 10.36 (s, 1H), 8.13 (s, 1H), 7.62 (s, 1H), 6.22 (s, 1H), 3.15 (s, 3H), 2.28 (s, 3H).
Workup
- customThe solvent was removed in vacuo
- customthe resulting paste was sonicated in 5 mL of DCM
- filtrationThe solid was filtered off
- washwashed with DCM
- customdried in vacuo
Sources & evidence
- ORD record
- ord-c0031c7dc2ac4445b076452d0b54aa2e
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07655666B2
Reaction notes
Loading…